Scientists from all over the world will meet up in Seattle October 22-23 to attend the Warren G. Magnuson Congress for a Global Diabetes Alliance. The initiative is intended to help fight the rapid rise of type 2 diabetes worldwide. International Diabetes Federation past president Pierre Lefebvre, who will be a speaker at the conference, says the need for such an alliance to fight the T2 global epidemic "could not be more urgent."

More than one hundred diabetes experts hailing from over twenty countries will attend the congress. There's one main goal: the discussion of how to help under-served populations, such as indigenous peoples. However, the more general problems - prevention, treatment and the possibility of a cure - will also be on the table. It is also hoped that the alliance can help change public perception of type 2 diabetes as a disease associated with affluence, when in fact it is spreading faster in poor, developing countries where people frequently lack access to medical care.

Organizers say this is the first global alliance on diabetes. Speaking of organizers: who's behind this anyway? Well, it's being convened by the Pacific Northwest Research Institute (PNRI). Incoming president of the American Diabetes Association, Dr. Paul Robertson, is president and scientific director of the PNRI. Warren G. Magnuson, for whom the conference is named, was a US senator and supporter of the sciences who died from diabetes complications in 1989.

The ADA and PNRI's Dr. Robertson is optimistic the organization can effect change: "The response from top experts from around the world to develop a global, multidisciplinary, collaborative endeavor focused on clinical research on diabetes has been overwhelming."

King County, Washington - following in the footsteps of New York - has banned restaurants from cooking foods in trans fats. King County is home to Seattle, the city famous for its generous rainfall and equally generous caffeine intake. The new rule stipulates that, in addition to the trans fats ban, all eateries in the Seattle-area must also provide nutritional information about menu items.

The trans fats ban was passed by the King County Board of Health in an effort to stem soaring rates of illnesses that are linked to obesity, like type 2 diabetes. Board members and their supporters (including a representative from the American Diabetes Association) argue the change will help turn the tide by improving eating habits. Their opponents, however, have vigorously argued that this is not true. Restaurant patrons already know they're choosing unhealthy foods, they argue, and this new law won't prevent them from ordering fatty and sugar-laden foods. "I have a six-letter word to describe them [the board members and their supporters]," says restaurant-owner Chris Clifford. "It's 'stupid.' You can't help stupid people." Ouch. Well, this is a case where only time can prove him right or wrong. Click here to read more on the new measures.

An area in Seattle, WA is reporting a two-fold increase in the number of diabetics, up from ten years ago. In addition to this -- type 1 diabetes is on the rise.

The numbers show that 84,000 adults (nearly 6% of the adult population of the county) were diagnosed with diabetes in 2006, compared with 2.8% in 1996. Even more are unaware they have the condition. Type 1 diabetes, for which there is no known prevention, is showing a dramatic increase in the area, as well.

A researcher involved in the study explains "this is not a question of raising awareness of diabetes anymore -- we're beyond that. We need to understand why people aren't listening." The comment pertains to type 2 diabetics and why they have not altered unhealthy lifestyles choices such as high-fat foods and not enough exercise. Both contribute to skyrocketing obesity rates. And obesity is a major risk factor for Type 2 diabetes, by far the most common form.

Seattle has one of the highest rates of type 1 diabetes in children under 5, and they don't know why. But early research shows that oral insulin in family members of those already diagnosed showed a 4 1/2-year delay in the onset of the disease.